BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33232285)

  • 1. Upregulation of KIF20A promotes tumor proliferation and invasion in renal clear cell carcinoma and is associated with adverse clinical outcome.
    Ren X; Chen X; Ji Y; Li L; Li Y; Qin C; Fang K
    Aging (Albany NY); 2020 Nov; 12(24):25878-25894. PubMed ID: 33232285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive bioinformatics analysis of KIF20A as a prognosis biomarker for clear cell renal cell carcinoma.
    Xie C; Yiu W; Mo Y
    Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):116-124. PubMed ID: 38650144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KIF20A expression as a prognostic indicator and its possible involvement in the proliferation of ovarian clear‑cell carcinoma cells.
    Kawai Y; Shibata K; Sakata J; Suzuki S; Utsumi F; Niimi K; Sekiya R; Senga T; Kikkawa F; Kajiyama H
    Oncol Rep; 2018 Jul; 40(1):195-205. PubMed ID: 29749467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DKC1 serves as a potential prognostic biomarker for human clear cell renal cell carcinoma and promotes its proliferation, migration and invasion via the NF‑κB pathway.
    Zhang M; Pan Y; Jiang R; Hou P; Shan H; Chen F; Jiang T; Bai J; Zheng J
    Oncol Rep; 2018 Aug; 40(2):968-978. PubMed ID: 29901172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma.
    Shi L; Xiao L; Heng B; Mo S; Chen W; Su Z
    Int Urol Nephrol; 2017 Jul; 49(7):1165-1176. PubMed ID: 28349447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kif20a inhibition reduces migration and invasion of pancreatic cancer cells.
    Stangel D; Erkan M; Buchholz M; Gress T; Michalski C; Raulefs S; Friess H; Kleeff J
    J Surg Res; 2015 Jul; 197(1):91-100. PubMed ID: 25953216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXM1/KIF20A axis promotes clear cell renal cell carcinoma progression via regulating EMT signaling and affects immunotherapy response.
    Fang K; Gong M; Liu D; Liang S; Li Y; Sang W; Zhu R
    Heliyon; 2023 Dec; 9(12):e22734. PubMed ID: 38125441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of proliferation and invasion by MicroRNA-590-5p via targeting PBRM1 in clear cell renal carcinoma cells.
    Xiao X; Tang C; Xiao S; Fu C; Yu P
    Oncol Res; 2013; 20(11):537-44. PubMed ID: 24063284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrantly activated Gli2-KIF20A axis is crucial for growth of hepatocellular carcinoma and predicts poor prognosis.
    Shi C; Huang D; Lu N; Chen D; Zhang M; Yan Y; Deng L; Lu Q; Lu H; Luo S
    Oncotarget; 2016 May; 7(18):26206-19. PubMed ID: 27036048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of KIF20A by transcription factor IRF6 affects the progression of renal clear cell carcinoma.
    Ma X; Wang X; Dong Q; Pang H; Xu J; Shen J; Zhu J
    Cancer Cell Int; 2021 May; 21(1):246. PubMed ID: 33941190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway.
    Dong D; Mu Z; Wei N; Sun M; Wang W; Xin N; Shao Y; Zhao C
    Biomed Pharmacother; 2019 Mar; 111():917-925. PubMed ID: 30841471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
    Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
    Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
    Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
    Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CLEC3B is downregulated and inhibits proliferation in clear cell renal cell carcinoma.
    Liu J; Liu Z; Liu Q; Li L; Fan X; Wen T; An G
    Oncol Rep; 2018 Oct; 40(4):2023-2035. PubMed ID: 30066941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin F and KIF20A, FOXM1 target genes, increase proliferation and invasion of ovarian cancer cells.
    Li Y; Guo H; Wang Z; Bu H; Wang S; Wang H; Fang H; Liu Z; Kong B
    Exp Cell Res; 2020 Oct; 395(2):112212. PubMed ID: 32771525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of KIF20A confers malignant phenotype of lung adenocarcinoma by promoting cell proliferation and inhibiting apoptosis.
    Zhao X; Zhou LL; Li X; Ni J; Chen P; Ma R; Wu J; Feng J
    Cancer Med; 2018 Sep; 7(9):4678-4689. PubMed ID: 30105795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Kinesin Family Member 20A Correlates with Disease Progression and Poor Prognosis in Human Nasopharyngeal Cancer: A Retrospective Analysis of 105 Patients.
    Liu SL; Lin HX; Qiu F; Zhang WJ; Niu CH; Wen W; Sun XQ; Ye LP; Wu XQ; Lin CY; Song LB; Guo L
    PLoS One; 2017; 12(1):e0169280. PubMed ID: 28081138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA lung cancer associated transcript 1 promotes proliferation and invasion of clear cell renal cell carcinoma cells by negatively regulating miR-495-3p.
    Wang LN; Zhu XQ; Song XS; Xu Y
    J Cell Biochem; 2018 Sep; 119(9):7599-7609. PubMed ID: 29932248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of KIF20A as a prognostic biomarker and therapeutic target for different subtypes of breast cancer.
    Nakamura M; Takano A; Thang PM; Tsevegjav B; Zhu M; Yokose T; Yamashita T; Miyagi Y; Daigo Y
    Int J Oncol; 2020 Jul; 57(1):277-288. PubMed ID: 32467984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Expression of KIF20A Is Associated with Poor Overall Survival and Tumor Progression in Early-Stage Cervical Squamous Cell Carcinoma.
    Zhang W; He W; Shi Y; Gu H; Li M; Liu Z; Feng Y; Zheng N; Xie C; Zhang Y
    PLoS One; 2016; 11(12):e0167449. PubMed ID: 27941992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.